First Header Logo Second Header Logo

Connection

Daniel Files to Sulfoxides

Back to Details
This is a "connection" page, showing publications Daniel Files has written about Sulfoxides.
Daniel Files
Connection Strength
0.209
Sulfoxides
  1. Files DC, Tacke F, O'Sullivan A, Dorr P, Ferguson WG, Powderly WG. Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19. PLoS Pathog. 2022 Jun; 18(6):e1010547.
    View in: PubMed
    Score: 0.209
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.